☰

Yu Zhan, Ph.D. - Publications

Affiliations: 
2011 Biology (Cell-Molecular Biology) The University of Toledo 
Area:
Molecular Biology, Cell Biology, Oncology
Tree Info Grants Similar researchers PubMed Report error

10 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Ran L, Murphy D, Sher J, Cao Z, Wang S, Walczak E, Guan Y, Xie Y, Shukla S, Zhan Y, Antonescu CR, Chen Y, Chi P. Abstract A15: Modeling sporadic gastrointestinal stromal tumor with BRAFV600E mutation Clinical Cancer Research. 24. DOI: 10.1158/1557-3265.Sarcomas17-A15  0.311
2017 Shukla S, Cyrta J, Murphy DA, Walczak EG, Ran L, Agrawal P, Xie Y, Chen Y, Wang S, Zhan Y, Li D, Wong EWP, Sboner A, Beltran H, Mosquera JM, et al. Aberrant Activation of a Gastrointestinal Transcriptional Circuit in Prostate Cancer Mediates Castration Resistance. Cancer Cell. PMID 29153843 DOI: 10.1016/J.Ccell.2017.10.008  0.303
2017 Ran L, Murphy D, Sher J, Cao Z, Wang S, Walczak E, Guan Y, Xie Y, Shukla S, Zhan Y, Antonescu CR, Chen Y, Chi P. ETV1-positive cells give rise to BRAFV600E mutant gastrointestinal stromal tumors. Cancer Research. PMID 28539323 DOI: 10.1158/0008-5472.Can-16-3510  0.325
2016 Zhan Y, Seregin SS, Chen J, Chen GY. Nod1 Limits Colitis-Associated Tumorigenesis by Regulating IFN-γ Production. Journal of Immunology (Baltimore, Md. : 1950). PMID 27183588 DOI: 10.4049/Jimmunol.1501822  0.357
2014 Liu S, Sun X, Wang M, Hou Y, Zhan Y, Jiang Y, Liu Z, Cao X, Chen P, Liu Z, Chen X, Tao Y, Xu C, Mao J, Cheng C, et al. A microRNA 221- and 222-mediated feedback loop maintains constitutive activation of NFκB and STAT3 in colorectal cancer cells. Gastroenterology. 147: 847-859.e11. PMID 24931456 DOI: 10.1053/J.Gastro.2014.06.006  0.335
2012 Zhan Y, Abi Saab WF, Modi N, Stewart AM, Liu J, Chadee DN. Mixed lineage kinase 3 is required for matrix metalloproteinase expression and invasion in ovarian cancer cells. Experimental Cell Research. 318: 1641-8. PMID 22652451 DOI: 10.1016/J.Yexcr.2012.05.002  0.614
2011 Zhan Y, Modi N, Stewart AM, Hieronimus RI, Liu J, Gutmann DH, Chadee DN. Regulation of mixed lineage kinase 3 is required for Neurofibromatosis-2-mediated growth suppression in human cancer. Oncogene. 30: 781-9. PMID 20890305 DOI: 10.1038/Onc.2010.453  0.777
2010 Zhan Y, Chadee DN. Inhibition of Cdc42-mediated activation of mixed lineage kinase 3 by the tumor suppressor protein merlin. Small Gtpases. 1: 183-186. PMID 21686274 DOI: 10.4161/Sgtp.1.3.14935  0.752
2009 Cole ET, Zhan Y, Abi Saab WF, Korchnak AC, Ashburner BP, Chadee DN. Mixed lineage kinase 3 negatively regulates IKK activity and enhances etoposide-induced cell death. Biochimica Et Biophysica Acta. 1793: 1811-8. PMID 19782705 DOI: 10.1016/J.Bbamcr.2009.09.014  0.626
2009 Korchnak AC, Zhan Y, Aguilar MT, Chadee DN. Cytokine-induced activation of mixed lineage kinase 3 requires TRAF2 and TRAF6. Cellular Signalling. 21: 1620-5. PMID 19586614 DOI: 10.1016/J.Cellsig.2009.06.008  0.722
Show low-probability matches.